drugset / Trial / NCT02903212

Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis

NCT02903212 ↗

Phase 1/2 Unknown 22 enrolled Centre Hospitalier Universitaire de Besancon
NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to determine the tolerance of apoptotic autologous cells injection in subjects with active rheumatoid arthritis.

Timeline

Start
2023-03
Primary completion
2024-06
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous apoptotic cells Cell therapy — Other

Indications